Stock Analysis
- United States
- /
- Medical Equipment
- /
- NYSEAM:ELMD
Undiscovered Gems in the US Stock Market for November 2024
Reviewed by Simply Wall St
The United States stock market has experienced a notable uptick, rising 2.0% over the last week and climbing 32% in the past year, with earnings projected to grow by 15% annually. In this thriving environment, identifying promising stocks that remain under the radar can offer unique opportunities for investors seeking to capitalize on potential growth.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Eagle Financial Services | 170.75% | 12.30% | 1.92% | ★★★★★★ |
Wilson Bank Holding | NA | 7.87% | 8.22% | ★★★★★★ |
Franklin Financial Services | 173.21% | 5.55% | -1.86% | ★★★★★★ |
Parker Drilling | 46.25% | -0.33% | 53.04% | ★★★★★★ |
Omega Flex | NA | 0.39% | 2.57% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.65% | 11.17% | ★★★★★★ |
Teekay | NA | -3.71% | 60.91% | ★★★★★★ |
ASA Gold and Precious Metals | NA | 7.11% | -35.88% | ★★★★★☆ |
Pure Cycle | 5.31% | -4.44% | -5.74% | ★★★★★☆ |
FRMO | 0.13% | 19.43% | 29.70% | ★★★★☆☆ |
Let's dive into some prime choices out of from the screener.
Energy Services of America (NasdaqCM:ESOA)
Simply Wall St Value Rating: ★★★★★★
Overview: Energy Services of America Corporation, along with its subsidiaries, offers contracting services to utilities and energy-related companies in the United States, with a market cap of $255.69 million.
Operations: Energy Services of America generates revenue primarily from its heavy construction segment, which accounts for $352.07 million. The company's financial performance is influenced by its ability to manage costs effectively in this area.
Energy Services of America, a smaller player in the energy sector, has seen remarkable earnings growth of 632% over the past year, significantly outpacing the industry average of 17%. This surge is partly due to a one-off gain of US$15.9M impacting recent financial results. The company's debt management appears prudent with a net debt to equity ratio at 33%, and interest payments are well covered by EBIT at an 8x coverage. However, future projections suggest challenges ahead with earnings forecasted to decline by an average of 78% annually over the next three years.
Northeast Community Bancorp (NasdaqCM:NECB)
Simply Wall St Value Rating: ★★★★★★
Overview: Northeast Community Bancorp, Inc. is the holding company for NorthEast Community Bank, offering financial services to individuals and businesses, with a market cap of $357.31 million.
Operations: NorthEast Community Bank generates revenue primarily from its thrift and savings and loan institutions, totaling $106.66 million.
Northeast Community Bancorp, with assets totaling US$2 billion and equity of US$309.6 million, is making waves in the banking sector. Its deposits stand at US$1.6 billion against loans of US$1.8 billion, showcasing a robust lending portfolio supported by a net interest margin of 6.4%. The company has an allowance for bad loans at 0.3%, indicating prudent risk management practices. Over the past year, earnings surged by 15%, outpacing the industry’s downturn of -12%. Trading below fair value by 22%, it offers potential upside while maintaining low-risk funding sources primarily through customer deposits.
- Get an in-depth perspective on Northeast Community Bancorp's performance by reading our health report here.
Understand Northeast Community Bancorp's track record by examining our Past report.
Electromed (NYSEAM:ELMD)
Simply Wall St Value Rating: ★★★★★★
Overview: Electromed, Inc. is a company that focuses on developing, manufacturing, marketing, and selling airway clearance therapy products using high frequency chest wall oscillation for pulmonary care across different age groups in the United States and internationally, with a market cap of $255.94 million.
Operations: Electromed generates revenue primarily from developing, manufacturing, and marketing medical equipment, with reported revenue of $57.06 million. The company's financial performance is influenced by its gross profit margin trends over time.
Electromed, a nimble player in the medical equipment space, has showcased impressive financial strides recently. Its earnings surged 99.7% over the past year, outpacing the industry's 10.4% growth rate. Trading at nearly 90% below its estimated fair value suggests potential undervaluation. The company is debt-free and boasts high-quality earnings, with recent sales hitting US$14.67 million compared to US$12.32 million last year and net income jumping to US$1.47 million from US$0.155 million previously reported for the same period a year ago. A recent buyback saw Electromed repurchase shares worth $4.54 million, reflecting confidence in its market position and future prospects.
Summing It All Up
- Reveal the 231 hidden gems among our US Undiscovered Gems With Strong Fundamentals screener with a single click here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Electromed might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSEAM:ELMD
Electromed
Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.